Quogue Capital
3
57M
3
1
3
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the New York. The company was established in North America in United States.
The overall number of key employees were 2.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Quogue Capital, startups are often financed by Three Arch Partners, Amgen Ventures, Alta Partners. The meaningful sponsors for the fund in investment in the same round are Frazier Healthcare Partners, Three Arch Partners, OrbiMed.
The increased amount of exits for fund were in 2011. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. The common things for fund are deals in the range of 50 - 100 millions dollars.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Biotechnology, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Iovance Biotherapeutics, Calistoga Pharmaceuticals The fund has exact preference in some founders of portfolio startups.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 3
- Investments by industry
- Biotechnology (3)
- Medical (2)
- Health Care (2)
- Alternative Medicine (1)
- Biopharma (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 125M
- Group Appearance index
- 1.00
- Avg. company exit year
- 5
- Avg. multiplicator
- 3.86
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Calistoga Pharmaceuticals | 30 Jun 2010 | Biotechnology, Medical, Alternative Medicine | Late Stage Venture | 40M | United States, Washington, Seattle |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.